Table 1. Patient characteristics Patient... | American Society of Hematology

Table 1.

Patient characteristics

Patient no.	Sex	Age, y	Histologic type	Stage	Extranodal involvement	LDH elevation	No. prior chemotherapy regimens	Prior high-dose therapy	Response to last therapy	Bulky disease	Outcome after RIT	Duration of response, mos.
1	F	57	DLBCL	IV	Yes	No	4	Yes	No	No	CR	42
2	M	63	MCL	III	Yes	No	4	Yes	Yes	No	CR^*	7
3	F	64	FL	IV	Yes	Yes	5	No	Yes	No	PD	—
4	M	25	DLBCL	II	Yes	Yes	5	Yes	No	Yes	MR	2

Patient no.	Sex	Age, y	Histologic type	Stage	Extranodal involvement	LDH elevation	No. prior chemotherapy regimens	Prior high-dose therapy	Response to last therapy	Bulky disease	Outcome after RIT	Duration of response, mos.
1	F	57	DLBCL	IV	Yes	No	4	Yes	No	No	CR	42
2	M	63	MCL	III	Yes	No	4	Yes	Yes	No	CR^*	7
3	F	64	FL	IV	Yes	Yes	5	No	Yes	No	PD	—
4	M	25	DLBCL	II	Yes	Yes	5	Yes	No	Yes	MR	2

Bulky disease indicates largest tumor manifestation greater than or equal to 10 cm; RIT, radioimmunotherapy; DLBCL, diffuse large B-cell lymphoma; CR, complete remission; MCL, mantle cell lymphoma; FL, follicular lymphoma; PD, progressive disease; —, not applicable (patient did not experience any remission); and MR, mixed response.

SD was documented initially after RIT and CR was achieved after additional chemotherapy.

View Large

This Feature Is Available To Subscribers Only